PharmaSea is funded by the European Union under its FP7 programme. The collaborative project will build upon a highly interdisciplinary consortium of 24 partners from 13 countries from industry, academia and non-profit organisations. World-leading experts from Belgium, UK, Norway, Spain, Ireland, Germany, Italy and Denmark as well as partners from China, South Africa, Chile, Costa Rica and New Zealand are taking part in the PharmaSea project. PharmaSea brings together researchers from the areas of marine genomics, biosynthesis and chemical structure analysis as well as legal experts.









 The EU 7FP project Micro B3 (Biodiversity, Bioinformatics, Biotechnology) will develop innovative bioinformatic approaches and a legal framework to make large-scale data on marine viral, bacterial, archaeal and protists genomes and metagenomes accessible for marine ecosystems biology and to define new targets for biotechnological applications. Micro B3 will build upon a highly interdisciplinary consortium of 32 academic and industrial partners comprising world-leading experts in bioinformatics, computer science, biology, ecology, oceanography, bioprospecting and biotechnology, as well as legal aspects.






BlueGenics From gene to bioactive product: Exploiting marine genomics for an innovative and sustainable European blue biotechnology industry   










MaCuMBA is led by the Royal Netherlands Institute for Sea Research (NIOZ) and is a joint venture of 23 partner institutions from 11 EU countries with the common aim to uncover the untold diversity of marine microbes using cultivation-dependent strategies.